Clinically, IL-10 is upregulated during the acute phase after moderate-to-severe TBI [52, 53], and several pre-clinical studies report neuroprotective effects of IL-10 treatment in acute brain injury that can be attributed to its anti-inflammatory activities [54–56]. Here, IL10 is linked to injury.